Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Vaccine|April 9, 1999
Humoral and cellular immunity induced by antigens adjuvanted with colloidal iron hydroxideH Leibl, R Tomasits, P Brühl, et al.
Protein Expression and Purification|May 25, 1999
Circular dichroism analysis of insect cell expressed herpes simplex virus type I single-stranded DNA-binding protein ICP8M Spatz, S A Ali, M Auer, et al.
Clinical Immunology and Immunopathology|April 1, 1984
Peripheral blood mononuclear cells of splenectomized patients are unable to differentiate into immunoglobulin-secreting cells after pokeweed mitogen stimulationC Müller, J W Mannhalter, R Ahmad, et al.
Cellular Immunology|March 1, 1984
Dialyzable leukocyte extract (transfer factor) in the treatment of superinfected fistulating tuberculosis of the boneC C Zielinski, E Savoini, M Ciotti, et al.
Cancer|October 15, 1986
Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapyC C Zielinski, I Stuller, F Dorner, et al.
Immunological Investigations|April 1, 1991
IgG subclasses and antibody response to pneumococcal capsular polysaccharides in children with severe sinopulmonary infections and asthmaE Bernatowska-Matuszkiewicz, M Pac, M Pum, et al.
Clinical and Experimental Immunology|July 1, 1985
Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentationJ W Mannhalter, H O Neychev, G J Zlabinger, et al.
Irish Journal of Medical Science|March 21, 2009
Heterozygous promotor haplotype LXA/LYB in MBL-deficiency associated with myopathy and left ventricular hypertrabeculation/noncompactionJ Finsterer, C Stöllberger, H M Wolf
Biochemical and Biophysical Research Communications|October 29, 1998
High level expression and structural characterisation of herpes simplex virus type I transcriptional activator VP16 (alpha-trans inducing factor)A M Spatz, S A Ali, M Auer, et al.
Journal of Clinical Immunology|May 23, 2000
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapyH M Chapel, G P Spickett, D Ericson, et al.
Pageof 13